Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 8, 2014
National survey of adult transplant hepatologists on the pediatric-to-adult care transition after liver transplantationMadeleine R Heldman, Min-Woong Sohn, Elisa J Gordon, et al.
Clinical Transplantation|December 31, 2024
Contemporary Cytomegalovirus (CMV) Infections in Low-Risk CMV Seronegative Recipients of Solid Organ Transplants From CMV Seronegative Donors (D-/R-): Time to Reexamine Donor CMV SerostatusMadeleine R Heldman, Julia A Messina, Annette J Schlueter, et al.
Analytical Biochemistry|July 31, 2013
Absolute quantitation of endogenous proteins with precision and accuracy using a capillary Western systemJin-Qiu Chen, Madeleine R Heldman, Michelle A Herrmann, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 24, 2022
Combined assessment of Epstein-Barr virus viral capsid antigen and Epstein-Barr virus nuclear antigen-1 serology for post-transplant lymphoproliferative disorder risk stratification in adult solid organ transplant recipientsMadeleine R Heldman, Kerstin L Edlefsen, Gregory Pepper, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 12, 2024
A practical guide to real-world implementation of pre-emptive therapy for Cytomegalovirus disease prevention in high-risk seronegative liver transplant recipients with seropositive donorsMadeleine R Heldman, Bailey Dunn, Evan Clemens, et al.
Molecular Cancer Therapeutics|August 28, 2013
Capillary isoelectric-focusing immunoassays to study dynamic oncoprotein phosphorylation and drug response to targeted therapies in non-small cell lung cancerJin-Qiu Chen, Jih-Hsiang Lee, Michelle A Herrmann, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 3, 2023
Real-world effectiveness of preemptive therapy (PET) for cytomegalovirus (CMV) disease prevention in CMV high-risk donor seropositive/recipient seronegative (D+R-) liver transplant recipients (LTxR)Kathleen M Doss, Catherine E Kling, Madeleine R Heldman, et al.
JHLT Open|April 17, 2025
Outcomes of lung transplantation from SARS-CoV-2 positive donors during the Omicron waveSonya M Kothadia, Cameron R Wolfe, Arthur W Baker, et al.
The Journal of Infectious Diseases|July 5, 2023
Serial Quantitation of Plasma Microbial Cell-Free DNA Before and After Diagnosis of Pulmonary Invasive Mold Infections After Hematopoietic Cell TransplantMadeleine R Heldman, Asim A Ahmed, Winnie Liu, et al.
Open Forum Infectious Diseases|July 3, 2024
Real-World Experience With Maribavir for Treatment of Cytomegalovirus Infection in High-Risk Solid Organ Transplant RecipientsBin Ni, Cameron R Wolfe, Sana Arif, et al.
Pageof 4